Global capabilities

Autoimmune neurological disorders can often be treated, sometimes with full restoration of function. However, because the symptoms mimic other conditions, autoimmune neurological disorders are frequently misdiagnosed, resulting in an irreversible loss of function.

Mayo Clinic's Center for Individualized Medicine (CIM) is nearing the finish line of the first stage of its unique RIGHT 10K study—an effort that doesn't involve running shoes but nevertheless is paving the way to prescribing medications matched to a person’s genetic code.

A movement disorder might be caused by the body’s immune system, which is meant to fight infections, suddenly attacking the brain. Fortunately, an “autoimmune movement disorder” can often be treated—once its cause is discovered.

Discussion is an effective pedagogical strategy to facilitate a learning experience and assess understanding. Carrie Bowler, Program Manager of Staff Development in the Department of Laboratory Medicine and Pathology, discusses the benefits of discussion as a strategy.

After a long wait, the U.S. Food and Drug Administration has finally approved the Elecsys Troponin T Gen 5 STAT blood test. Recently, the Beckman hscTnI assay was also approved. These high-sensitivity troponin assays will benefit emergency departments across the country because the results will allow for earlier and faster recognition of acute myocardial infarction, which interrupts the blood supply to an area of the heart.

How Your Genes Determine which Medications Work Best for You The drugs available today to treat diseases are powerful agents that work as intended for[...]

This “Phlebotomy” webinar will discuss how a patient’s “experience” is the entirety of all the interactions that person has had within the health care system. Each member of a health care team plays a role in enhancing patient satisfaction, which contributes to the patient experience.

Mayo Medical Laboratories, the global reference laboratory of Mayo Clinic, has changed its name to Mayo Clinic Laboratories.

Reilly Hannon, a student in the Mayo Clinic Medical Laboratory Science program, reflects on her course in hemostasis.

Effective November 9, 2018, our business name will change from Mayo Collaborative Services, LLC, doing business as (d/b/a) Mayo Medical Laboratories to Mayo Collaborative Services, LLC, d/b/a Mayo Clinic Laboratories. The change to Mayo Clinic Laboratories will more accurately reflect the benefit we are able to bring to our clients every day.

Necrotizing autoimmune myopathy (NAM) is a serious but rare muscle disease strongly associated with autoantibodies to either the protein signal recognition particle (SRP) or the enzyme 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR). NAM typically manifests with subacute proximal limb muscle weakness and persistently elevated serum creatine kinase (CK) concentrations, but slower onsets can occur and complicate diagnosis.

Chromium and cobalt blood tests are used to monitor exposure to these elements. Both of these elements are naturally occurring and widely distributed in the environment. Previously, serum samples were collected and used to monitor patients with metal-on-metal implants, but serum can easily be contaminated during the harvesting and separation of the serum from the cellular blood components causing incorrect results. By using the new EDTA anticoagulated whole-blood test, which is collected in a trace element tube instead of using serum, the risk of contamination is significantly reduced.